Corrections
===========


The following information was mistakenly omitted from a recent article.1Steven Grover has conducted research supported by Pfizer, Bristol-Myers Squibb, Aventis and AstraZeneca. He has received consulting fees from Pfizer and AstraZeneca and speaker fees from Pfizer, Oryx and Aventis. He owns stock in Pfizer, Merck, Bristol-Myers Squibb and Kos.

## Reference

1.  1. Hemmelgarn BR, Grover S, Feldman RD, for the Canadian Hypertension Education Program. Applying the 2005 Canadian Hypertension Education Program recommendations: 2. Assessing and reducing global atherosclerotic risk among hypertensive patients. *CMAJ* 2005;173(6):593-5.